Genepath Diagnostics India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-12-2024
- Paid Up Capital ₹ 10.00 K
as on 05-12-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 80.88%
(FY 2022)
- Profit -40.09%
(FY 2022)
- Ebitda -25.88%
(FY 2022)
- Net Worth -130.13%
(FY 2022)
- Total Assets 48.13%
(FY 2022)
About Genepath Diagnostics India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Christopher Kolenaty and Nikhil Phadke serve as directors at the Company.
- CIN/LLPIN
U74999PN2019PTC181759
- Company No.
181759
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jan 2019
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Genepath Diagnostics India Private Limited offer?
Genepath Diagnostics India Private Limited offers a wide range of products and services, including Computer & Mobile Apps Development, Application Development Service, Diagnostic Imaging & Pathology Labs, Medical Test Services, Blood Testing, Rapid Test Kit, Diagnostic Test Kit, Custom Application Development.
Who are the key members and board of directors at Genepath Diagnostics India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikhil Phadke  | Director | 29-Jan-2019 | Current |
Christopher Kolenaty  | Director | 11-Apr-2019 | Current |
Financial Performance and Corporate Structure Insights of Genepath Diagnostics India.
Genepath Diagnostics India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 80.88% increase. The company also saw a substantial fall in profitability, with a 40.09% decrease in profit. The company's net worth observed a substantial decline by a decrease of 130.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genepath Diagnostics India?
In 2022, Genepath Diagnostics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Snow Leopard Global Technology- Iii LlpActive 3 years 11 monthsChristopher Kolenaty is a mutual person
Causeway Healthcare Private LimitedActive 16 years 9 monthsChristopher Kolenaty and Nikhil Phadke are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genepath Diagnostics India?
Genepath Diagnostics India has a workforce of 52 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genepath Diagnostics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genepath Diagnostics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
